newdrugapprovals.org
FDA approves first biosimilar to Neulasta, Fulphila (pegfilgrastim) to help reduce the risk of infection during cancer treatment
FDA approves first biosimilar to Neulasta to help reduce the risk of infection during cancer treatment The U.S. Food and Drug Administration today approved Fulphila (pegfilgrastim-jmdb) as the firs…